Blood pressure medication recalled nationwide: FDA
The FDA has issued a nationwide recall for more than 11,000 bottles of the blood pressure drug chlorthalidone. The recall stems from a manufacturing issue involving failed dissolution specifications. This defect may render the medication ineffective.
What changed
The recall is now identified as affecting chlorthalidone tablets from Inventia Healthcare Limited.
Live updates
-
FDA Recalls Over 11,000 Bottles of Chlorthalidone Blood Pressure Medication
confidence 100%The FDA has issued a nationwide recall for more than 11,000 bottles of the blood pressure drug chlorthalidone. The recall stems from a manufacturing issue involving failed dissolution specifications. This defect may render the medication ineffective.
What's confirmed:
- The FDA announced a nationwide recall of more than 11,000 bottles of blood pressure medication.
- The recalled drug is chlorthalidone.
- The recall is due to a manufacturing issue where the medication failed dissolution specifications.
- The manufacturing defect may cause the medication to be ineffective.
Still unconfirmed:
- Inventia Healthcare Limited is the manufacturer of the recalled tablets.
-
FDA Recalls Over 11,000 Bottles of Chlorthalidone Blood Pressure Medication
confidence 100%The FDA has announced a nationwide recall of more than 11,000 bottles of the blood pressure drug chlorthalidone. The medication was recalled due to manufacturing issues and failed dissolution specifications. This defect may cause the drug to be ineffective.
What's confirmed:
- The FDA recalled more than 11,000 bottles of blood pressure medication nationwide.
- The recalled drug is chlorthalidone.
- The recall is due to a manufacturing issue involving failed dissolution specifications.
- The dissolution failure may render the medication ineffective.
Still unconfirmed:
- Inventia Healthcare Limited is the manufacturer of the recalled tablets.